Share Issue/Capital Change • Mar 1, 2023
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
Registered Office: 6 THEOTOKIS, 3RD FLOOR, 1055 NICOSIA, CYPRUS Registration Number: 415277
1 st March 2023
Mr. Nikos Tripatsas Acting General Manager Cyprus Stock Exchange Nicosia
With the present, iDNA Genomics Public Ltd (the "Company") would like to inform the investing public that,
the Board of Directors of the Company (the "Board") decided the issuance and allotment of 700 Bonds and total value €700.000, being the first tranche.
The Board will take all necessary actions for the listing of the Bond to the Bond Market of the Emerging Companies Market of the Cyprus Stock Exchange.
The Company may issue additional tranches of the Bond up until the 28th of December 2023, bringing the total value of the Bond to up to €6.000.000 (six million EUR).
Kind regards,
Prusec Limited Secretary on behalf of the Board of Directors
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.